tiprankstipranks
Advertisement
Advertisement

LUCD Stock Latest News

Lucid Diagnostics price target raised to $9.50 from $9.25 at Ascendiant
The FlyLucid Diagnostics price target raised to $9.50 from $9.25 at Ascendiant
10d ago
LUCD
Lucid Diagnostics Earnings Call Balances Progress and Risk
PremiumCompany Announcements
Lucid Diagnostics Earnings Call Balances Progress and Risk
16d ago
LUCD
Analyst Reaffirms Buy on Lucid Diagnostics, Sees Upside to $2.50 Target on Coverage Momentum and Validated EsoGuard Utility
PremiumRatings
Analyst Reaffirms Buy on Lucid Diagnostics, Sees Upside to $2.50 Target on Coverage Momentum and Validated EsoGuard Utility
20d ago
LUCD
Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c)
PremiumThe Fly
Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c)
20d ago
LUCD
Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision
PremiumCompany Announcements
Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision
24d ago
8K
LUCD
Is LUCD a Buy, Before Earnings?
PremiumPre-EarningsIs LUCD a Buy, Before Earnings?
26d ago
LUCD
Lucid announces Concert issued positive coverage policy for EsoGuard test
Premium
The Fly
Lucid announces Concert issued positive coverage policy for EsoGuard test
1M ago
LUCD
PAVM
Lucid Diagnostics Shareholders Approve Stock Authorization Increase
Premium
Company Announcements
Lucid Diagnostics Shareholders Approve Stock Authorization Increase
2M ago
8K
LUCD
Lucid Diagnostics price target lowered to $2 from $3 at Maxim
PremiumThe Fly
Lucid Diagnostics price target lowered to $2 from $3 at Maxim
4M ago
LUCD
Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst
PremiumRatings
Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst
4M ago
LUCD
Lucid Diagnostics Earnings Call Balances Progress, Pressure
PremiumCompany Announcements
Lucid Diagnostics Earnings Call Balances Progress, Pressure
4M ago
LUCD
Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)
PremiumThe Fly
Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)
4M ago
LUCD
Buy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target
PremiumRatingsBuy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target
4M ago
LUCD
Lucid Diagnostics Reports Q1 2026 Results and Outlook
Premium
Company Announcements
Lucid Diagnostics Reports Q1 2026 Results and Outlook
4M ago
8K
LUCD
LUCD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LUCD Earnings this Week: How Will it Perform?
4M ago
LUCD
Lucid Diagnostics Raises Capital Through Direct Share Offering
PremiumCompany Announcements
Lucid Diagnostics Raises Capital Through Direct Share Offering
4M ago
8K
LUCD
Lucid Diagnostics Prices $18 Million Public Equity Offering
PremiumCompany Announcements
Lucid Diagnostics Prices $18 Million Public Equity Offering
5M ago
8K
LUCD
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering
PremiumThe Fly
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering
5M ago
LUCD
Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
PremiumRatings
Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating
5M ago
LUCD
Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
PremiumThe FlyLucid Diagnostics price target raised to $9 from $8.25 at Ascendiant
5M ago
LUCD
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
Premium
Company Announcements
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain
5M ago
LUCD
Is LUCD a Buy, Before Earnings?
Premium
Pre-Earnings
Is LUCD a Buy, Before Earnings?
5M ago
LUCD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >